#United States #Pittsburgh #Upsher-Smith #PANTHERx Rare #VIGAFYDE

PANTHERx® Rare Partners with Upsher-Smith for VIGAFYDE™ Distribution

In a significant development for pediatric healthcare, PANTHERx® Rare has been selected by Upsher-Smith Laboratories, LLC as the specialty pharmacy responsible for distributing VIGAFYDE™ (vigabatrin). This treatment is tailored for infants aged one month to two years suffering from infantile spasms, a serious condition that necessitates prompt intervention.

Infantile spasms are a rare neurological disorder characterized by clusters of short seizures and sudden stiffening of muscles, primarily affecting an infant's head, neck, arms, and legs. Typically manifesting between three to eight months of age, these spasms can arise in otherwise healthy infants but are often linked to underlying issues such as genetic disorders or brain injuries. Without timely diagnosis and treatment, they can lead to lasting neurological damage, developmental delays, and complications like epilepsy and intellectual disabilities.

The announcement comes at a time when families dealing with such challenges are in dire need of accessible treatment options. "Parents with children suffering from infantile spasms face numerous concerns and obstacles in their care," stated Rob Snyder, Executive Chairman of PANTHERx® Rare Pharmacy. "At PANTHERx, we have extensive experience supporting these families, ensuring that essential medications are delivered promptly to enable home care as soon as possible." Their approach focuses on efficiently providing VIGAFYDE™ to parents, giving children the opportunity to receive necessary treatment without unnecessary delays post-hospitalization.

PANTHERx® Rare stands out in the realm of specialty pharmacies, exclusively dedicated to rare and orphan diseases. Their commitment is backed by dual accreditation, which includes the prestigious Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs. Moreover, PANTHERx has earned accolades such as the MMIT Patient Choice Award multiple times, underscoring its reputation for excellence in patient satisfaction.

As a leader in delivering critical medications and patient support, PANTHERx Rare continues to transform lives through its comprehensive services. Based in Pittsburgh, Pennsylvania, the pharmacy maintains licensure across all 50 states and U.S. territories, ensuring widespread accessibility to its services. This partnership with Upsher-Smith marks a significant step towards enhancing the support available to families facing the daunting challenges associated with infantile spasms.

The distribution of VIGAFYDE™ through PANTHERx is a testament to their dedication to improving patient outcomes and ensuring that children affected by this rare condition receive the timely and efficient care they need. As the healthcare landscape evolves, partnerships like this one underscore the importance of specialization in delivering effective treatments to vulnerable populations.

For more information regarding VIGAFYDE™ (vigabatrin) and its application for infantile spasms, healthcare providers and interested parties can consult the prescribing information directly or contact PANTHERx Rare Pharmacy.